COLL
Price:
$37.19
Market Cap:
$1.20B
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-05-07
Stock Exchange
NASDAQ
Ticker
COLL
According to Collegium Pharmaceutical, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.58B. This represents a change of 10.30% compared to the average of 1.44B of the last 4 quarters.
The mean historical Enterprise Value of Collegium Pharmaceutical, Inc. over the last ten years is 649.08M. The current 1.58B Enterprise Value has changed 24.31% with respect to the historical average. Over the past ten years (40 quarters), COLL's Enterprise Value was at its highest in in the March 2024 quarter at 1.66B. The Enterprise Value was at its lowest in in the September 2014 quarter at 0.
Average
649.08M
Median
490.77M
Minimum
103.20M
Maximum
1.48B
Discovering the peaks and valleys of Collegium Pharmaceutical, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 174.75%
Maximum Annual Enterprise Value = 1.48B
Minimum Annual Increase = -19.34%
Minimum Annual Enterprise Value = 103.20M
Year | Enterprise Value | Change |
---|---|---|
2023 | 1.47B | -0.68% |
2022 | 1.48B | 104.70% |
2021 | 724.94M | -7.26% |
2020 | 781.66M | 44.74% |
2019 | 540.06M | 25.76% |
2018 | 429.43M | -2.73% |
2017 | 441.48M | 93.04% |
2016 | 228.70M | -19.34% |
2015 | 283.53M | 174.75% |
2014 | 103.20M | 21.06% |
The current Enterprise Value of Collegium Pharmaceutical, Inc. (COLL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
1.23B
5-year avg
1.00B
10-year avg
649.08M
Collegium Pharmaceutical, Inc.’s Enterprise Value is greater than Phibro Animal Health Corporation (1.24B), greater than ANI Pharmaceuticals, Inc. (1.34B), greater than Procaps Group S.A. (491.27M), greater than Silver Spike Investment Corp. (38.06M), less than Amphastar Pharmaceuticals, Inc. (2.64B), greater than Eagle Pharmaceuticals, Inc. (110.03M), less than Alkermes plc (4.26B), greater than Evolus, Inc. (961.20M), less than Prestige Consumer Healthcare Inc. (4.75B), greater than Regencell Bioscience Holdings Limited (85.96M), greater than Pacira BioSciences, Inc. (1.04B), less than Intra-Cellular Therapies, Inc. (7.09B), less than Dr. Reddy's Laboratories Limited (1.13T),
Company | Enterprise Value | Market cap |
---|---|---|
1.24B | $788.20M | |
1.34B | $1.27B | |
491.27M | $218.91M | |
38.06M | $71.22M | |
2.64B | $2.21B | |
110.03M | $55.19M | |
4.26B | $4.42B | |
961.20M | $928.12M | |
4.75B | $3.68B | |
85.96M | $87.06M | |
1.04B | $638.86M | |
7.09B | $7.77B | |
1.13T | $13.19B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Collegium Pharmaceutical, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Collegium Pharmaceutical, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Collegium Pharmaceutical, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Collegium Pharmaceutical, Inc. (COLL)?
What is the 3-year average Enterprise Value for Collegium Pharmaceutical, Inc. (COLL)?
What is the 5-year average Enterprise Value for Collegium Pharmaceutical, Inc. (COLL)?
How does the current Enterprise Value for Collegium Pharmaceutical, Inc. (COLL) compare to its historical average?